Literature DB >> 10639388

In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species.

K A Hammer1, C F Carson, T V Riley.   

Abstract

The in vitro activities of ketoconazole, econazole, miconazole, and tea tree oil against 54 Malassezia isolates were determined by agar and broth dilution methods. Ketoconazole was more active than both econazole and miconazole, which showed very similar activities. M. furfur was the least susceptible species. M. sympodialis, M. slooffiae, M. globosa, and M. obtusa showed similar susceptibilities to the four agents.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10639388      PMCID： PMC89709          DOI： 10.1128/AAC.44.2.467-469.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro.

Authors:  K A Hammer; C F Carson; T V Riley
Journal:  J Appl Microbiol       Date:  1999-03       Impact factor: 3.772

2.  The antimicrobial activity of tea tree oil.

Authors:  C F Carson; T V Riley
Journal:  Med J Aust       Date:  1994-02-21       Impact factor: 7.738

3.  The genus Malassezia with description of four new species.

Authors:  E Guého; G Midgley; J Guillot
Journal:  Antonie Van Leeuwenhoek       Date:  1996-05       Impact factor: 2.271

4.  Differentiation of Malassezia species: selectivity of cremophor EL, castor oil and ricinoleic acid for M. furfur.

Authors:  P Mayser; P Haze; C Papavassilis; M Pickel; K Gruender; E Guého
Journal:  Br J Dermatol       Date:  1997-08       Impact factor: 9.302

5.  The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons.

Authors:  J Guillot; E Guého
Journal:  Antonie Van Leeuwenhoek       Date:  1995       Impact factor: 2.271

6.  Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro.

Authors:  P Nenoff; U F Haustein; W Brandt
Journal:  Skin Pharmacol       Date:  1996

7.  In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia.

Authors:  K A Hammer; C F Carson; T V Riley
Journal:  J Med Vet Mycol       Date:  1997 Sep-Oct

8.  The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs.

Authors:  J Van Cutsem; F Van Gerven; J Fransen; P Schrooten; P A Janssen
Journal:  J Am Acad Dermatol       Date:  1990-06       Impact factor: 11.527

9.  Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole.

Authors:  D S Buck; D M Nidorf; J G Addino
Journal:  J Fam Pract       Date:  1994-06       Impact factor: 0.493

10.  The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.

Authors:  F Van Gerven; F C Odds
Journal:  Mycoses       Date:  1995 Sep-Oct       Impact factor: 4.377
View more
  12 in total

Review 1.  Malassezia (pityrosporum) folliculitis.

Authors:  Richard M Rubenstein; Sarah A Malerich
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 2.  Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties.

Authors:  C F Carson; K A Hammer; T V Riley
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.

Authors:  S Rincón; M C Cepero de García; A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 4.  Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.

Authors:  Ané Orchard; Sandy van Vuuren
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-04       Impact factor: 2.629

5.  Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology.

Authors:  Christina M Gemmer; Yvonne M DeAngelis; Bart Theelen; Teun Boekhout; Thomas L Dawson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

6.  In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.

Authors:  Margarita Garau; Manolo Pereiro; Amalia del Palacio
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods.

Authors:  Tomasz Jagielski; Elżbieta Rup; Aleksandra Ziółkowska; Katarzyna Roeske; Anna B Macura; Jacek Bielecki
Journal:  BMC Dermatol       Date:  2014-03-07

8.  Susceptibility variation of Malassezia pachydermatis to antifungal agents according to isolate source.

Authors:  Caroline Borges Weiler; Francielli Pantella Kunz de Jesus; Graziela Habib Nardi; Erico Silva Loreto; Janio Morais Santurio; Selene Dall'acqua Coutinho; Sydney Hartz Alves
Journal:  Braz J Microbiol       Date:  2013-03-26       Impact factor: 2.476

9.  Exploration of anti-Malassezia potential of Nyctanthes arbor-tristis L. and their application to combat the infection caused by Mala s1 a novel allergen.

Authors:  Rohit K Mishra; Vani Mishra; Anand Pandey; Amit K Tiwari; Himanshu Pandey; Shivesh Sharma; Avinash C Pandey; Anupam Dikshit
Journal:  BMC Complement Altern Med       Date:  2016-03-31       Impact factor: 3.659

10.  Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.

Authors:  Andrew G S Warrilow; Claire L Price; Josie E Parker; Nicola J Rolley; Christopher J Smyrniotis; David D Hughes; Vera Thoss; W David Nes; Diane E Kelly; Theodore R Holman; Steven L Kelly
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.